158
Views
14
CrossRef citations to date
0
Altmetric
Research Article

DEET-loaded solid lipid particles for skin delivery: In vitro release and skin permeation characteristics in different vehicles

, , &
Pages 315-327 | Received 26 Jun 2005, Accepted 10 Sep 2005, Published online: 08 Oct 2008

References

  • Bolgül Y, Hekimoğlu S, Sahin-Erdemli I, Kas HS. Evaluation of oxyprenolol hydrochloride permeation through isolated human skin and pharmacodynamic effect in rats. STP Pharma Sciences 1998; 8: 197–201
  • Bonazzi D, Gotti R, Gatti R, Cavrini V. Derivative UV spectroscopy: Some useful applications in pharmaceutical analysis. Il Farmaco 1997; 52: 193–197
  • Cavalli R, Caputto O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug free and drug-loaded solid lipid nanoparticles. International Journal of Pharmaceutics 1997; 148: 47–54
  • Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. International Journal of Pharmaceutics 2002; 238: 241–245
  • Couch P, Johnson CE. Prevention of the lyme disease. American Journal of Health-System Pharmacy 1992; 49: 1164–1173
  • Domb AJ. Lipospheres for controlled drug delivery of substances. US Patent 5 188 837, 1993
  • Domb AJ, Marlinsky A, Maniar M, Teomim L. Insect repellent formulations of N,N-diethyl-m-toluamide (DEET) in aliposphere system: Efficacy and skin uptake. Journal of Mosquito Control Association 1995; 11: 29–34
  • Freitas C, Müller RH. Spray-drying of solid lipid nanoparticles (SLN™). European Journal of Pharmaceutics & Biopharmaceutics 1998; 46: 1145–1151
  • Iscan Y, Wissing SA, Hekimoglu S, Müller RH. Solid lipid nanoparticles (SLN™) for topical drug delivery: Incorporation of the lipophilic drugs DEET and vitamin K. Pharmazie 2005; 60(12)
  • Jaiswal J, Poduri R, Ponchagnuia R. Transdermal delivery of naloxane: Ex vivo permeation studies. International Journal of Pharmaceutics 1999; 179: 129–134
  • Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. European Journal of Pharmaceutics & Biopharmaceutics 2000; 49: 211–218
  • Kurul E, Hekimoglu S. Skin permeation of two different benzophenone derivatives from various vehicles. International Journal of Cosmetic Science 2001; 23: 211–218
  • Lipscomb JW, Kramer JE, Leikin JB. Seizure following brief exposure to the insect repellent N,N-diethyl-m-toluamide. Annals of Emergency Medicine 1992; 21: 315–317
  • Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. International Journal of Pharmaceutics 2000; 196: 165–167
  • Milutinovic R, Vuleta G, Milic J, Stajkovic N. Assessment of efficiency of repellent formulations with N,N-dimethyl-m-toluamide in laboratory conditions. International Journal of Cosmetic Science 1999; 21: 7–14
  • Müller RH, Maaβen S, Weyhers H, Specht F, Luck JS. Cytotoxicity of magnetide loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. International Journal of Pharmaceutics 1996; 138: 85–94
  • Müller RH, Mehnert W, Lucks JS, Schwarz C, Zur A, Weyhers H, Freitas C, Rühl D. Solid lipid particles (SLN)—an alternative colloidal carrier system for controlled drug delivery. European Journal of Pharmaceutics & Biopharmaceutics 1995; 41: 62–69
  • Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advances Drug Delivery Reviews 2002; 54(Suppl. 1)S131–S155
  • Proniuk S, Liederer BM, Dixon SE, Rein JA, Kallen MA, Blanchard J. Topical formulations studies with DEET (N,N-diethyl-3-methylbenzamide) and cyclodextrins. Journal of Pharmaceutical Sciences 2002; 91: 101–110
  • Qui H, McCall JW, Jun HW. Formulation of topical insect repellent N,N-diethyl-m-toluamide (DEET): Vehicle effects on DEET in vitro skin permeation. International Journal of Pharmaceutics 1998; 163: 167–176
  • Reuveni H, Yagupsky P. Diethyltoluamide containing insect repellent. Adverse effects in worldwide use. Archives of Dermatology 1982; 18: 582–583
  • Robbins P, Chernak MG. Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-n-toluamide (DEET). Journal of Toxicology & Environmental Health 1986; 18: 503–525
  • Schoenig GP, Hartnagel RE, Scharden JL, Vorhees CV. Neurotoxicity evaluation of N,N-diethyl-m-toluamide (DEET) in rats. Fundamental Applied Toxicology 1993; 21: 355–365
  • Schwarb FP, Imanidis G, Smith EW, Haigh JM, Surber C. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharmaceutical Research 1999; 16: 909–915
  • Smith K. Penetrant characteristics influencing skin absorption. Methods for skin absorption, BW Kemppainen, WG Reifenrath. CRC Press, Boca Raton, Ann Arbor, MA 1990; 23–33
  • Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics 2004; 278: 71–77
  • Stinecipher J, Shah J. Percutaneous permeation of N,N-diethyl-m-toluamide (DEET) from commercial mosquito repellents and the effect of solvent. Journal of Toxicology & Environmental Health 1997; 52: 119–135
  • Stinecipher J, Shah J. Percutaneous permeation of the meta, orto and para isomers of N,N-diethyltoluamide. International Journal of Pharmaceutics 1998; 160: 31–41
  • Wagner H, Kostka KH, Lehr CM, Schafer UF. Correlation between stratum corneum/water-partition coefficient and amounts of flufenamic acid penetrated in to the stratum corneum. Journal of Pharmaceutical Sciences 2002; 91: 1915–1921
  • Westesen K, Siekmann B. Biodegredable colloidal drug systems based on solid lipids. Microencapsulation methods and industrial applications, S Benita. Marcel Dekker, New York 1996; 213–258
  • Zimmermann E, Müller RH, Mäder K. Influence of different parameters of reconstitution of lyophilized SLN. International Journal of Pharmaceutics 2000; 196: 211–213

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.